Printer Friendly

PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID

PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID
 ALLEGAN, Mich., Jan. 22 /PRNewswire/ -- The Perrigo Company (NASDAQ-NMS: PRGO) announced today that it has been given approval by the Food and Drug Administration (FDA) to manufacture and market Loperamide Hydrochloride Liquid to the store brand market. Loperamide Hydrochloride Liquid is an over-the-counter drug indicated for the control and symptomatic relief of acute, non-specific diarrhea.
 Loperamide Hydrochloride Liquid is comparable to the nationally advertised brand Imodium AD Liquid, which switched from prescription to over-the-counter in March 1988. The company believes it is one of the first to receive approval for this product through the FDA's Abbreviated New Drug Application (ANDA) process.
 Perrigo will begin national distribution of this new store brand product to retailers and wholesalers in the next 60 days. The receipt of this approval is a couple of months ahead of Perrigo's anticipated timing.
 Perrigo Company is the nation's largest manufacturer of over-the- counter (non-prescription) pharmaceuticals and personal care products for the store brand market. Store brand products are sold under a retailer's own label and compete with nationally advertised brand name products. The company's customers are major national and regional retail drug, supermarket and mass merchandise chains and major wholesalers. The company's products include over-the-counter pharmaceuticals (such as analgesics, cough and cold remedies, antacids, laxatives, suppositories and diet products), personal care products (such as toothpaste and mouthwash, hair care products, deodorants and antiperspirants, baby care products, and skin care and sun care products), and vitamins.
 -0- 1/22/92
 /CONTACT: M. James Gunberg of Perrigo Company, 616-673-8451/
 (PRGO) CO: Perrigo Company ST: Michigan IN: MTC HEA SU: PDT


KK -- DE022 -- 2485 01/22/92 16:45 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 22, 1992
Words:279
Previous Article:PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID
Next Article:/C O R R E C T I O N -- CBOE/
Topics:


Related Articles
PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID
PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE CAPLET
PERRIGO COMPANY REPORTS RECORD QUARTER OF SALES AND EARNINGS
PERRIGO COMPANY ANNOUNCES RECORD QUARTER OF SALES AND EARNINGS
WATSON PHARMACEUTICALS ANNOUNCES FDA APPROVAL FOR LOPERAMIDE HYDROCHLORIDE ORAL SOLUTION
WATSON PHARMACEUTICALS ANNOUNCES FDA APPROVAL FOR VERAPIMIL HYDROCHLORIDE TABLET
A.L. LABORATORIES ANNOUNCES FDA APPROVAL FOR LOPERAMIDE CAPLETS
Perrigo Receives FDA Tentative Approval For Children's Ibuprofen Oral Suspension
Perrigo Company Receives FDA Approval To Manufacture and Market Two New Products.
Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters